Ben Sessa

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Impact of psychedelics on craving in addiction: A systematic review.

Impact of psychedelics on craving in addiction: A systematic review.

Journal: Journal of psychopharmacology (Oxford, England)

Published: February 01, 2025

MDMA-assisted psychotherapy for AUD: Bayesian analysis of WHO drinking risk level and exploratory analysis of drinking behavior and psychosocial functioning at 3 months follow-up.

MDMA-assisted psychotherapy for AUD: Bayesian analysis of WHO drinking risk level and exploratory analysis of drinking behavior and psychosocial functioning at 3 months follow-up.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire)

Published: January 05, 2025

Reply to: 5-MeO-DMT has not been found in traditional ayahuasca preparations and the combination of 5-MeO-DMT with MAOIs is dangerous.

Reply to: 5-MeO-DMT has not been found in traditional ayahuasca preparations and the combination of 5-MeO-DMT with MAOIs is dangerous.

Journal: Human psychopharmacology

Published: February 23, 2022

The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics.

The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics.

Journal: Journal of psychoactive drugs

Published: January 10, 2022

Debunking the myth of 'Blue Mondays': No evidence of affect drop after taking clinical MDMA.

Debunking the myth of 'Blue Mondays': No evidence of affect drop after taking clinical MDMA.

Journal: Journal of psychopharmacology (Oxford, England)

Published: December 13, 2021

N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine.

N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine.

Journal: Human psychopharmacology

Published: September 06, 2021

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder.

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder.

Journal: Journal of psychopharmacology (Oxford, England)

Published: February 19, 2021

Psilocybin occasioned mystical-type experiences.

Psilocybin occasioned mystical-type experiences.

Journal: Human psychopharmacology

Published: November 15, 2019

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants.

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants.

Journal: BMJ case reports

Published: July 17, 2019

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy.

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy.

Journal: Frontiers in psychiatry

Published: December 19, 2018

Why MDMA therapy for alcohol use disorder? And why now?

Why MDMA therapy for alcohol use disorder? And why now?

Journal: Neuropharmacology

Published: September 20, 2017

The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant.

The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant.

Journal: Psychopharmacology

Published: May 08, 2017

Showing 1-12 of 24

Last Updated: 09/26/2026